Tag: Cancer: Skin
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Lymph Node Dissection Declining in SLN-Positive Melanoma
From 2017 to 2019, increase seen in use of adjuvant systemic therapy, with variation in use among treating centers
Acral Lentiginous Melanoma Survival Varies by Race, SES
Differences in socioeconomic status contribute to survival disparities for Hispanic Black and White patients
Knowledge of High Skin Cancer Risk Might Modify Risky Behaviors
Those at high risk of skin cancer accurately assessed risk and reported lower likelihood of future tanning bed use
Metastases Occur in About 2 Percent of Cutaneous SCCs
Risk factors for metastases include age, male sex, and immunosuppression
Relatlimab-Nivolumab Ups PFS in Untreated Advanced Melanoma
Combination provides greater benefit than nivolumab alone for progression-free survival in untreated metastatic or unresectable melanoma
High-Fiber Diet May Benefit Melanoma Patients on Immunotherapy
Higher intake of dietary fiber linked to longer progression-free survival in melanoma patients on immune checkpoint blockade
Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma
Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib
Most Teens, Young Adults Knowledgeable About Sun Protection
While most report sunscreen use, substantial number also report having had sunburns
Review Profiles Open-Access Datasets With Skin Cancer Images
Darker skin types underrepresented among publicly available skin image datasets used to inform skin cancer diagnosis
